Detailed answers about GREATLION MEDICAL TECHNOLOGY LIMITED, including incorporation, status, business activity, and accounts information.
When was GREATLION MEDICAL TECHNOLOGY LIMITED founded?
GREATLION MEDICAL TECHNOLOGY LIMITED was officially incorporated on 27 December 2024 and is registered under company number 16152557. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GREATLION MEDICAL TECHNOLOGY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of GREATLION MEDICAL TECHNOLOGY LIMITED?
GREATLION MEDICAL TECHNOLOGY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does GREATLION MEDICAL TECHNOLOGY LIMITED do?
GREATLION MEDICAL TECHNOLOGY LIMITED operates in the following sectors: 46190 - Agents involved in the sale of a variety of goods, 62020 - Information technology consultancy activities, 70221 - Financial management, 74990 - Non-trading company. These SIC codes provide insight into the company's business activities and industry focus.
What is GREATLION MEDICAL TECHNOLOGY LIMITED's registered address?
The registered office address of GREATLION MEDICAL TECHNOLOGY LIMITED is SUITE 108 CHASE BUSINESS CENTRE, 39-41 CHASE SIDE, LONDON, UNITED KINGDOM, N14 5BP. This is the official address filed with Companies House for legal and statutory correspondence.
Is GREATLION MEDICAL TECHNOLOGY LIMITED financially stable?
Financial accounts for GREATLION MEDICAL TECHNOLOGY LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.